House Dust Mite Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
House dust mite allergy is an allergic reaction to tiny bugs that commonly live in house dust. Symptoms include frequent sneezing, a runny, stuffy, itchy nose and irritated eyes. Asthma and eczema can also be triggered by a dust mite allergy. Symptoms often worsen when the individual comes in close proximity to disturbed dust.
The House Dust Mite Allergy – Drugs In Development research report provides a comprehensive overview on the therapeutics under development for House Dust Mite Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for House Dust Mite Allergy and features dormant and discontinued projects.
Key Target in the House Dust Mite Allergy Pipeline Drugs Market
The key target in the House Dust Mite Allergy pipeline drugs market is Der p 2 Allergen.
Key RoA in the House Dust Mite Allergy Pipeline Drugs Market
The key RoA in the House Dust Mite Allergy pipeline drugs market are sublingual, topical, nasal, intradermal, and subcutaneous.
House Dust Mite Allergy Pipeline Drugs Market, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the House Dust Mite Allergy Pipeline Drugs Market
The key molecule types in the House Dust Mite Allergy pipeline products market are Allergenics (Allergen), DNA Vaccine, and Vaccine.
To get more insights on key molecule types, download a free sample report
Major Companies in the House Dust Mite Allergy Pipeline Drugs Market
The major companies in the House Dust Mite Allergy pipeline drugs market are Allergy Therapeutics Plc, ALK-Abello AS, Advagene Biopharma Co Ltd, Astellas Pharma Inc, Stallergenes Greer Ltd, Worg Pharmaceuticals, Roxall Medizin GmbH, and Genetic Immunity Inc.
House Dust Mite Allergy Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
House Dust Mite Allergy Pipeline Drugs Market Overview
Key target | Der p 2 Allergen |
Key routes of administration | Sublingual, Topical, Nasal, Intradermal, and Subcutaneous |
Key molecule types | Allergenics (Allergen), DNA Vaccine, and Vaccine |
Key companies | Allergy Therapeutics Plc, ALK-Abello AS, Advagene Biopharma Co Ltd, Astellas Pharma Inc, Stallergenes Greer Ltd, Worg Pharmaceuticals, Roxall Medizin GmbH, and Genetic Immunity Inc.
|
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of House Dust Mite Allergy
- The pipeline guide reviews pipeline therapeutics for House Dust Mite Allergyby companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in House Dust Mite Allergy therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates House Dust Mite Allergy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for House Dust Mite Allergy
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for House Dust Mite Allergy
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding House Dust Mite Allergypipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
ALK-Abello AS
Allergy Therapeutics Plc
Astellas Pharma Inc
Genetic Immunity Inc
Roxall Medizin GmbH
Stallergenes Greer Ltd
Worg Pharmaceuticals Hangzhou Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What is the key target in the House Dust Mite Allergy pipeline products market?
The key target in the House Dust Mite Allergy pipeline products market is Der p 2 Allergen.
-
What are the key routes of administration in the House Dust Mite Allergy pipeline products market?
The key routes of administration in the House Dust Mite Allergy pipeline products market are sublingual, topical, nasal, intradermal, and subcutaneous.
-
What are the different molecule types in the House Dust Mite Allergy pipeline products market?
The different molecule types in the House Dust Mite Allergy pipeline products market are Allergenics (Allergen), DNA Vaccine, and Vaccine.
-
What are the major companies in the House Dust Mite Allergy pipeline drugs market?
The major companies in the House Dust Mite Allergy pipeline products market are Allergy Therapeutics Plc, ALK-Abello AS, Advagene Biopharma Co Ltd, Astellas Pharma Inc, Stallergenes Greer Ltd, Worg Pharmaceuticals, Roxall Medizin GmbH, and Genetic Immunity Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.